Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Shitalben R Patel"'
Autor:
Adam Bress, Jin Han, Shitalben R Patel, Ankit A Desai, Ibrahim Mansour, Vicki Groo, Kristin Progar, Ebony Shah, Thomas D Stamos, Coady Wing, Joe G N Garcia, Rick Kittles, Larisa H Cavallari
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e71268 (2013)
The objective of this study was to examine the extent to which aldosterone synthase genotype (CYP11B2) and genetic ancestry correlate with atrial fibrillation (AF) and serum aldosterone in African Americans with heart failure. Clinical data, echocard
Externí odkaz:
https://doaj.org/article/e417c8d65c39463190e3d4e5b3409f65
Autor:
Eric Wenzler, Mark Biagi, Shitalben R. Patel, David A Butler, Samah Qasmieh, Minh Hong Nguyen, Ryan K. Shields, Xing Tan, Ryan M. Rivosecchi, Cornelius J. Clancy, K Tejani
Publikováno v:
Antimicrob Agents Chemother
The pharmacokinetics (PK) and dialytic clearance of isavuconazole in vitro and in 7 solid-organ transplant patients undergoing continuous renal replacement therapy (CRRT) were evaluated. In vivo, the mean (± standard deviation [SD]) plasma PK parame
Publikováno v:
Antimicrobial Agents and Chemotherapy. 63
Objective: Metallo-β-lactamase (MBL)-producing Enterobacteriaceae, particularly those that co-harbor serine β-lactamases, are a serious emerging public health threat given their rapid dissemination and the limited number of treatment options. Pre-c
Autor:
Eric Wenzler, Shane Brandt, Shitalben R. Patel, J. Thielke, Patricia West-Thielke, Enrico Benedetti, Shree Patel, Natalia M. Jasiak‐Panek, Yi‐jen Huang, Kristin Progar
Publikováno v:
Clinical Transplantation. 33
Purpose Tacrolimus extended-release (TAC-ER; Astagraf XL® ) is utilized in many immunosuppressive regimens post-renal transplantation. Current dosing recommendation for the TAC-ER in renal transplant is 0.15-0.2 mg/kg/day administered once daily. Th
Publikováno v:
The FASEB Journal. 33
Autor:
Nina Los, Gail B. Mahady, Shitalben R. Patel, Zarema Arbieva, Mark Maienschein-Cline, Pinal Kanabar, Temitope O. Lawal
Publikováno v:
Functional Foods in Health and Disease. 11:154
Integrated systems biology approaches suggest that combinations of nutrients may be more effective against cancer due to the large number of signaling pathways associated with cancer initiation and promotion. In a previous work, we have reported that
Autor:
Tracie D. Locklear, Gail B. Mahady, Udeshi Patel, Alice L. Perez, Lorraina Hernandez, Shitalben R. Patel, Brian J. Doyle, Temitope O. Lawal
Publikováno v:
Pharmaceutical Biology, Vol 56, Iss 1, Pp 235-244 (2018)
Context: Pimenta dioica (L.) Merr. (Myrtaceae) is used in Costa Rican traditional medicine for women’s health. Our previous work showed that P. dioica extracts were oestrogenic. Objectives: This work identifies phytochemicals from P. dioica that ar
Publikováno v:
Pharmacogenomics. 15:1717-1722
The CYP2C9 c.449G>A (p.R150H, rs7900194) polymorphism, which confers the CYP2C9*8 allele, is common in persons of African descent and results in reduced clearance of the narrow therapeutic index drugs, warfarin and phenytoin. Because of significant h
Publikováno v:
Functional Foods in Health and Disease. 9:749
Background: Vitamin D was first hypothesized to play a role in cancer chemoprevention in 1980 when it was observed that there was a higher rate of colon cancer in the Northern USA as compared with populations living in the South. While cholecalcifero
Autor:
Kimberly Freeman, Danxin Wang, Shitalben R. Patel, Hyunyoung Jeong, David Vaynshteyn, Larisa H. Cavallari, Minoli A. Perera, Katrzyna Drozda, Harumi Takahashi
Publikováno v:
Pharmacogenetics and Genomics. 23:228-231
Cytochrome P450 2C9 (CYP2C9) c.449G> A (*8) is common in African Americans and is associated with decreased warfarin clearance. We examined the effect of promoter region variants inherited with 449G > A on warfarin clearance, dose requirements, and C